TITLE

Combined donor specific transfusion and anti-CD154 therapy achieves airway allograft tolerance

AUTHOR(S)
Chalermskulrat, W.; McKinnon, K. P.; Brickey, W. J.; Neuringer, I. P.; Park, R. C.; Sterka, D. G.; Long, B. R.; McNeillie, P.; Noelle, R. J.; Ting, J. P.; Aris, R. M.
PUB. DATE
January 2006
SOURCE
Thorax;Jan2006, Vol. 61 Issue 1, p61
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Background: The state of tolerance allows long term graft survival without immunosuppressants. Lung transplantation tolerance has not been consistently achieved in either small or large animal models.Methods: The mechanisms and effectiveness of a tolerance induction protocol consisting of donor specific transfusion (DST; day 0) and a short course of co-stimulatory blockade (anti-CD154 antibody; days -7, -4, 0 and +4) were studied in the mouse heterotopic tracheal transplant model of chronic lung rejection. C57BL/6 mice received BALB/c tracheal grafts (day 0) and were treated with DST alone, anti-CD154 alone, the combination (DST/anti-CD154), or no treatment. No non-specific immunosuppressants were used.Results: DST/anti-CD154 in combination, but neither treatment alone, markedly prolonged the lumen patency and survival (>100 days) of fully histo-incompatible allografts (p<0.05 versus control allografts at every time point studied up to 16 weeks) without immunosuppression. This protocol was donor antigen specific as third party grafts (C3H) were promptly rejected. In addition, DST/anti-CD154 did not result in mixed chimerism but induced transplantation tolerance via a peripheral mechanism(s), which included significantly reduced cytotoxic T cell activity (p<0.001) and a significantly increased percentage of CD4+CD25+ cells (p = 0.03).Conclusions: The DST/anti-CD154 protocol successfully induced and maintained long term, donor specific tolerance in the mouse heterotopic airway graft model of chronic lung rejection. This finding may lead us closer to successful tolerance induction in lung transplantation.
ACCESSION #
20089486

 

Related Articles

  • Chronic Rejection Pathology after Orthotopic Lung Transplantation in Mice: The Development of a Murine BOS Model and Its Drawbacks. Vleeschauwer, St�phanie De; Jungraithmayr, Wolfgang; Wauters, Shana; Willems, Stijn; Rinaldi, Manuela; Vaneylen, Annemie; Verleden, Stijn; Willems-Widyastuti, Anna; Bracke, Ken; Brusselle, Guy; Verbeken, Erik; Raemdonck, Dirk Van; Verleden, Geert; Vanaudenaerde, Bart // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Almost all animal models for chronic rejection (CR) after lung transplantation (LTx) fail to resemble the human situation. It was our attempt to develop a representative model of CR in mice. Orthotopic LTx was performed in allografts receiving daily immunosuppression with steroids and...

  • Chronic Rejection Pathology after Orthotopic Lung Transplantation in Mice: The Development of a Murine BOS Model and Its Drawbacks. Vleeschauwer, Stéphanie De; Jungraithmayr, Wolfgang; Wauters, Shana; Willems, Stijn; Rinaldi, Manuela; Vaneylen, Annemie; Verleden, Stijn; Willems-Widyastuti, Anna; Bracke, Ken; Brusselle, Guy; Verbeken, Erik; Raemdonck, Dirk Van; Verleden, Geert; Vanaudenaerde, Bart // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Almost all animal models for chronic rejection (CR) after lung transplantation (LTx) fail to resemble the human situation. It was our attempt to develop a representative model of CR in mice. Orthotopic LTx was performed in allografts receiving daily immunosuppression with steroids and...

  • Stem cells–meet immunity. Heng, Tracy S. P.; Dudakov, Jarrod A.; Khong, Danika M. P.; Chidgey, Ann P.; Boyd, Richard L. // Journal of Molecular Medicine;Nov2009, Vol. 87 Issue 11, p1061 

    The ability of stem cells to differentiate into various different cell types holds great promise for the treatment of irreversible tissue damage that occurs in many debilitating conditions. With stem cell research advancing at a tremendous pace, it is becoming clear that one of the greatest...

  • Novel insights and strategies in immunosuppressive therapy in allograft transplantation. Ebrahimi, Ammar // HealthMed;2014, Vol. 8 Issue 5, p614 

    Long-term survival for transplant patients remains problematic despite improvement in organ preservation methods, surgical procedures, new immunosuppressive therapy regimens and intensive care administration. This has led to increased interest in alternative approaches to immunosuppression...

  • Trichilemmal Carcinoma In a Lung Transplant Recipient. Hamodat, Mowafak; Ryan, Suzanne C.; Wadden, Patricia M. // Internet Journal of Pathology;2009, Vol. 8 Issue 1, p19 

    Trichilemmal carcinoma is a rarely diagnosed cutaneous adnexal neoplasm. It is derived from or differentiates towards the outer root sheath of the hair follicle and is the malignant counterpart of trichilemmonma. Here we report a case of TLCA that developed in a 68 year old male lung transplant...

  • New Developments In Treatment After Lung Transplantation. Benden, Christian; Danziger-Isakov, Lara; Faro, Albert // Current Pharmaceutical Design;2/11/2012, Vol. 18 Issue 5, p737 

    Lung transplantation has evolved as an accepted therapy in selected adults and children with end-stage lung disease. Outcomes following lung transplantation have improved in the recent era with a 5-year survival of >70% and an overall good functional status of surviving recipients. Many of the...

  • Aqueous extract of Caesalpinia sappan decelerates allograft rejection by inducing imbalance between CD4+ CD25+ T cells and Th17 cells. Chunxia Li; Hui Zhang; Qun Ma; Zhihua Li; Jun Dai; Chuanping Si; Dongqin Gao; Mingyan Zhang // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 5, p7107 

    Objective: Aqueous extract of Caesalpinia sappan (CSE) has immunosuppressive activities, but the mechanism remains unknown. This study was to investigate the effect of CSE on the balance between CD4+ CD25+ T cells and Th17 cells. Methods: Allografted Balb/c recipients were intraperitoneally...

  • Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation. Lim, Eu Jin; Chin, Ruth; Nachbur, Ueli; Silke, John; Jia, Zhiyuan; Angus, Peter W.; Torresi, Joseph // PLoS ONE;9/21/2015, Vol. 10 Issue 9, p1 

    Introduction: Immunosuppressants are used ubiquitously post-liver transplantation to prevent allograft rejection. However their effects on hepatocytes are unknown. Experimental data from non-liver cells indicate that immunosuppressants may promote cell death thereby driving an inflammatory...

  • Immunosuppressive drugs after lung transplantation. Briffa, Norman; Morris, Randall E. // BMJ: British Medical Journal (International Edition);03/07/98, Vol. 316 Issue 7133, p719 

    Editorial. Introduces several immunosuppresive drugs that may improve long term survival after lung transplantation. Survival figures after lung transplantation; Main cause of death after transplantation; Outcome of trials on the efficacy of cyclosporin (Neoral, Novartis), FK506 (Tacrolimus)...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics